Investigational Drug Information for Surotomycin
✉ Email this page to a colleague
What is the drug development status for Surotomycin?
Surotomycin is an investigational drug.
There have been 4 clinical trials for Surotomycin.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 16th 2012.
The most common disease conditions in clinical trials are Diarrhea, Clostridium Infections, and [disabled in preview]. The leading clinical trial sponsors are Cubist Pharmaceuticals LLC, Merck Sharp & Dohme Corp., and [disabled in preview].
Summary for Surotomycin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 19 |
| WIPO Patent Applications | 20 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2012-05-16) |
| Vendors | 5 |
Recent Clinical Trials for Surotomycin
| Title | Sponsor | Phase |
|---|---|---|
| Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) | Cubist Pharmaceuticals LLC | Phase 3 |
| A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) | Cubist Pharmaceuticals LLC | Phase 3 |
| A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009) | Merck Sharp & Dohme Corp. | Phase 1 |
Clinical Trial Summary for Surotomycin
Top disease conditions for Surotomycin
Top clinical trial sponsors for Surotomycin
US Patents for Surotomycin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
